Stablecoin Development Corp
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
SDEV$0.89-9.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ITEM 6. | EXHIBITS |
|---|
The following exhibits are filed with or incorporated by reference into this report.
EXHIBIT INDEX
| Incorporation by Reference · Filed Herewith | |||||
|---|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | File Number | Exhibit/ Form 8-K Item Reference | Filing Date |
| 3.1 | Second Amended and Restated Certificate of Incorporation of Stablecoin Development Corporation | 8-K | 001-33678 | 3.1 | 3/12/2026 |
| 3.2 | Amendment to the Second Amended and Restated Certificate of Incorporation, dated March 31, 2026 | 8-K | 001-33678 | 3.1 | 4/01/2026 |
| 3.3 | Bylaws, as amended and restated effective April 2, 2026 | 8-K | 001-33678 | 3.2 | 4/01/2026 |
| 4.1 | Form of Amended November 2021 Warrant | 8-K | 001-33678 | 4.2 | 9/13/2022 |
| 4.2 | Form of September 2022 Warrant (2020 participants) | 8-K | 001-33678 | 4.3 | 9/13/2022 |
| 4.3 | Form of September 2022 Warrant (2021 participants) | 8-K | 001-33678 | 4.4 | 9/13/2022 |
| 4.4 | Form of Series A-1 Long-Term Warrant | 8-K | 001-33678 | 4.5 | 9/13/2022 |
| 4.5 | Form of Series F-1 Common Stock Warrant | 8-K | 001-33678 | 4.1 | 7/29/2024 | |
| 4.6 | Form of Pre-Funded Warrant | 8-K | 001-33678 | 4.1 | 1/16/2026 | |
| 10.1* | Securities Purchase Agreement, by and among NovaBay Pharmaceuticals, Inc., R01 Fund LP, Framework Ventures IV L.P., Tether Investments, S.A. de C.V. and Sky Frontier Foundation, dated January 16, 2026 | 10-K | 001-33678 | 10.45 | 3/19/2026 | |
| 10.2* | Investors’ Rights Agreement, by and among NovaBay Pharmaceuticals, Inc., R01 Fund LP, Framework Ventures IV L.P., Tether Investments, S.A. de C.V. and Sky Frontier Foundation, dated January 16, 2026 | 8-K | 001-33678 | 10.2 | 1/16/2026 | |
| 10.3 | NovaBay Pharmaceuticals, Inc. 2026 Equity Incentive Plan | 8-K | 001-33678 | 10.1 | 4/01/2026 | |
| 10.4 | Form of Restricted Stock Unit Agreement (Time-Based) (Michael Kazley) | 8-K | 001-33678 | 10.2 | 4/01/2026 | |
| 10.5 | Form of Restricted Stock Unit Agreement (Time-Based) | 8-K | 001-33678 | 10.3 | 4/01/2026 | |
| 10.6* | Form of Restricted Stock Unit Agreement (Performance-Based) (Michael Kazley) | 8-K | 001-33678 | 10.4 | 4/01/2026 | |
| 10.7+* | Employment Agreement, dated March 31, 2026, by and between NovaBay Pharmaceuticals, Inc. and Michael Kazley | 8-K | 001-33678 | 10.5 | 4/01/2026 | |
| 10.8+* | Employment Agreement, dated March 31, 2026, by and between NovaBay Pharmaceuticals, Inc. and Tommy Law | 8-K | 001-33678 | 10.6 | 4/01/2026 | |
| 31.1 | Certification of the Principal Executive Officer of Stablecoin Development Corporation, as required by Rule 13a-14(a) or Rule 15d-14(a) | X | ||||
| 31.2 | Certification of the Principal Financial Officer of Stablecoin Development Corporation, as required by Rule 13a-14(a) or Rule 15d-14(a) | X | ||||
| 32.1 | Certification by the Chief Executive Officer of Stablecoin Development Corporation, as required by Rule 13a-14(b) or 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) | X | ||||
| 32.2 | Certification by the Chief Financial Officer of Stablecoin Development Corporation, as required by Rule 13a-14(b) or 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) | X | ||||
| 101.INS | Inline XBRL Instance Document | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | X | ||||
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document | X | ||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X | ||||
| 104 | The Cover Page Interactive Data File, formatted in Inline XBRL (included within the Exhibit 101 attachments) | X | ||||
| + | Indicates a management contract or compensatory plan or arrangement. |
|---|---|
| * | Certain schedule and exhibits were omitted as well as confidential portions of this exhibit by means of marking such portions with brackets because the confidential portions (i) are not material and the type of information that is typically treated as private or confidential and/or (ii) would be competitively harmful if publicly disclosed. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.